Skoči na glavni sadržaj

Pregledni rad

Safety of long-term proton pump inhibitors use

Ivana Mikolašević ; Zavod za gastroenterologiju, KBC Rijeka, Rijeka
Lidija Orlić ; Zavod za nefrologiju, dijalizu i transplantaciju bubrega, KBC Rijeka, Rijeka
Vojko Mavrinac ; Zavod za gastroenterologiju, KBC Rijeka, Rijeka
Davor Štimac ; Zavod za gastroenterologiju, KBC Rijeka, Rijeka
Danijela Ostojić ; Zavod za kardiovaskularne bolesti, KBC Rijeka, Rijeka
Valentino Rački ; Medicinski fakultet Sveučilišta u Rijeci, Rijeka
Ivan Jakopčić ; Medicinski fakultet Sveučilišta u Rijeci, Rijeka
Franjo Carović ; Medicinski fakultet Sveučilišta u Rijeci, Rijeka
Mila Prskalo ; Medicinski fakultet Sveučilišta u Rijeci, Rijeka
Sandra Milić ; Zavod za gastroenterologiju, KBC Rijeka, Rijeka


Puni tekst: hrvatski pdf 723 Kb

str. 148-156

preuzimanja: 8.718

citiraj


Sažetak

Proton pump inhibitors (PPI) are the drugs that have brought a revolution as a treatment of choice for various conditions associated with increased secretion of gastric acid; peptic ulcers, gastroesophageal reflux disease, functional dyspepsia. Although PPIs are widely prescribed and generally safe drugs, recently increased attention was focused on the potential adverse effects of these drugs. Given the increasing number of patients receiving PPI’s, long-term potential adverse effects of this class of drugs are gaining increasing attention. However, most of recent investigations raise the possibility that elderly and malnourished patients have a higher risk for these side effects.

Ključne riječi

adverse effects; gastroenterology; proton pump inhibitors

Hrčak ID:

158494

URI

https://hrcak.srce.hr/158494

Datum izdavanja:

1.6.2016.

Podaci na drugim jezicima: hrvatski

Posjeta: 9.897 *